Drugs / Death mesenchymal stem cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06021067 | Sep 2023 → Sep 2024 | radiation pneumonitis | Sichuan University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Death mesenchymal stem cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06021067 ↗ |
| Modality | Cell therapy | “a pre-specified starting dose of dead mesenchymal stem cells” NCT06021067 ↗ |
| Route | Other | “infusion every 3 days” NCT06021067 ↗ |